Semaglutide for treating metabolic dysfunction-associated steatohepatitis with liver fibrosis [ID6458]

  • In development
  • GID-TA11477
  • Expected publication date: TBC

NIHRIO BN: 13408-Semaglutide-for-Non-Alcoholic-Steatohepatitis-V1.0-OCT2023-NON-CONF.pdf (nihr.ac.uk)